Abstract:IMPORTANCE: Globally, treatment-resistant depression affects approximately one-third of all patients diagnosed with major depressive disorder. Currently, there are neither behavioral nor neural measures that quantitatively phenotype characteristics underlying treatment-resistant depression. OBJECTIVE: Determine whether neurocomputational models that integrate information about adaptive behavior and associated self-reported feelings can characterize differences in patients with treatment-resistant depression. DESIGN: In this observational study, data were collected over two research visits from 2020-2023 that occurred before and after standard-of-care electroconvulsive therapy (ECT) for treatment-resistant depression. This report focuses on Visit 1, which occurred after patients consented to ECT but before their initial treatment. SETTING: Wake Forest University School of Medicine; Atrium Health Wake Forest Baptist Psychiatric Outpatient Center; Atrium Health Wake Forest Hospital. PARTICIPANTS: Participants planning to receive ECT for depression (pre-ECT) and participants not planning to receive ECT with (non-ECT) or without depression (no-depression), were recruited from the Psychiatric Outpatient Center and community. EXPOSURES: Computerized delivery of a Probabilistic Reward and Punishment with Subjective Rating task during fMRI. MAIN OUTCOMES AND MEASURES: Computational modeling of choice behavior provided parameters that characterized learning dynamics and associated affect dynamics expressed through intermittent Likert scale self-reports. Multivariate statistical analyses relating model parameters, neurobehavioral responses, and clinical assessments. RESULTS: Pre-ECT (N=29; 55.2% female), non-ECT (N=40; 70% female), and no-depression (N=41; 65.9% female). Parameters derived from computational models fit to behavior elicited during learning and the expression of affective experiences clearly differentiates the three groups. Reinforcement Learning model parameters alone do not perform as well as models that incorporate affective self-reports. Notably, the set of model parameters that include learning and affective dynamics demonstrated excellent, cross-validated, diagnostic classification of depression diagnosis. Prior to ECT, neurobehavioral responses associated with learning and affective experiences about "punishing" events were significantly impaired in pre-ECT compared to non-ECT and no-depression cohorts. CONCLUSIONS AND RELEVANCE: Computational models of behavioral dynamics associated with learning and affect can describe specific hypotheses about neurocomputational-mechanisms underlying treatment-resistant depression. The present work suggests differences in processing of emotionally negative states and suggests a potential model-based behavioral diagnostic for individuals with major depression. Such models may eventually be used to augment the diagnosis of treatment-resistant depression or possibly determine phenotype-genotype relationships for disease status and progression.

Response Trajectories During Escitalopram Treatment of Patients with Major Depressive Disorder

Predicting Escitalopram Monotherapy Response in Depression: the Role of Anterior Cingulate Cortex

Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study

Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder

Combining machine learning algorithms for prediction of antidepressant treatment response

Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge

Optimizing Antidepressant Efficacy: Generalizable Multimodal Neuroimaging Biomarkers for Prediction of Treatment Response

Subphenotyping Depression Using Machine Learning and Electronic Health Records

Using deep learning and pretreatment EEG to predict response to sertraline, bupropion, and placebo

Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report

Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response from Major Depressive Disorder

Patterns of Pretreatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results From the EMBARC Randomized Clinical Trial

Individual deviations from normative electroencephalographic connectivity predict antidepressant response

Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder

One size does not fit all: notable individual variation in brain activity correlates of antidepressant treatment response

Predictors of Electroconvulsive Therapy Outcome in Major Depressive Disorder

Computational Phenotyping of Treatment-Resistant Depression prior to Electroconvulsive Therapy

Ensemble Learning for Early‐Response Prediction of Antidepressant Treatment in Major Depressive Disorder

Connectivity of the Cognitive Control Network During Response Inhibition as a Predictive and Response Biomarker in Major Depression: Evidence From a Randomized Clinical Trial

Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment.